© Copyright 2025
Limited Time: Receive 30% off your first treatment
Get StartedA pitcher’s worst nightmare is hearing that they need to have Tommy John surgery. The surgery has an extremely long recovery period, and pitchers may not always return to their original pitching performance.
Thankfully, regenerative cell treatments are beginning to make a difference in helping to heal injuries that, in the past, would require Tommy John surgery. Some MLB players have even used regenerative cell therapy in hopes they could avoid Tommy John surgery. Before we get into how regenerative cells can help prevent Tommy John’s operation, it may be helpful to understand the history behind Tommy John’s surgery and what causes it.
The ulnar collateral ligament (UCL) is a critical component of the elbow joint, responsible for stabilizing the arm during various motions, particularly the repetitive throwing actions common in sports like baseball. This ligament is often subjected to extreme stress, especially among pitchers, leading to injuries ranging from minor inflammation to severe tears requiring surgical intervention. This article explores UCL injuries, their causes, treatments like Tommy John surgery, and emerging alternatives such as regenerative cell therapies.
The UCL is a triangular band of tissue located on the inside of the elbow. Its primary role is to stabilize the joint during dynamic activities such as throwing. Repeated high-intensity actions, such as pitching, subject the UCL to significant tensile stress, leading to overuse injuries.
In baseball, repetitive throwing motions place immense strain on the UCL. Pitchers often experience wear and tear after years of gameplay, culminating in injuries that can sideline them for extended periods.
Young athletes who focus exclusively on one sport early in life are at higher risk. Unlike multi-sport athletes, they do not develop a balanced set of muscles, tendons, and ligaments, increasing the likelihood of overuse injuries. Studies highlight a strong correlation between cumulative pitch counts and UCL tears, underscoring the need for preventive measures.
Tommy John surgery, named after the baseball pitcher who first underwent the procedure in 1974, involves reconstructing the UCL using a tendon from another part of the body, such as the forearm or hamstring.
When Tommy John underwent this experimental surgery, his return to the mound was uncertain. However, the procedure was a success, allowing him to continue his career and achieve significant milestones.
Surgeons replace the damaged ligament with a tendon graft, securing it to the bones in the elbow. This is followed by an extensive rehabilitation process lasting up to 18 months.
As sports become increasingly competitive, the prevalence of Tommy John surgery has surged, particularly among teenagers. Alarmingly, nearly two-thirds of these surgeries are performed on adolescents.
Despite its high success rate (approximately 85%), Tommy John surgery presents several challenges:
While many pitchers recover, studies reveal that only 53% return to their pre-injury playing potential. The reconstructed ligament is often less robust than the original, limiting a player’s pitching duration and velocity.
Post-surgery, other parts of the body, such as the shoulder, may absorb the stress previously handled by the UCL. This phenomenon, known as adjacent segment pathology, can lead to new injuries.
Rehabilitation typically spans 12 to 18 months. For professional athletes, this means missing critical games or even entire seasons, often during the prime of their careers.
Recent studies suggest that regenerative cells, including platelet-rich plasma (PRP), could offer a viable alternative to Tommy John surgery. In one study, 34 pitchers with partial UCL tears received PRP injections. Remarkably, 30 returned to competition within an average of 12 weeks, significantly shorter than the recovery time for surgery.
Stem cell treatments could also be used prophylactically to repair microtears and reduce strain on the UCL before a complete rupture occurs. This approach may help pitchers extend their careers and remain injury-free.
Los Angeles Angels pitchers Andrew Heaney and Garrett Richards sought regenerative cell therapy in 2016 to avoid Tommy John surgery. While Richards successfully returned to play, Heaney ultimately required surgery, illustrating both the promise and limitations of current regenerative treatments.
New methodologies combining PRP, dermal allografts, and stem cells show promise in enhancing ligament healing. For example, one pitcher who underwent this experimental procedure regained pre-injury performance levels, pitching at 86 mph after recovery.
The continued development of regenerative therapies could revolutionize UCL injury treatment. Advanced approaches, such as creating scaffolds to support PRP and stem cells, are already yielding encouraging results.
To reduce UCL injuries, athletes should prioritize: Balanced Training: Avoid early specialization and develop well-rounded physical conditioning. Preventive Treatments: Incorporate physical therapy and regenerative cell therapy to address early signs of ligament strain. Consult with healthcare professionals to explore innovative treatments like regenerative cells, which may reduce recovery time and eliminate the need for invasive surgery.
Tommy John surgery has long been the gold standard for treating severe UCL injuries, but its drawbacks and lengthy recovery times make alternatives like regenerative cell therapy increasingly appealing. As research progresses, these therapies could transform how pitchers and other athletes manage and prevent UCL injuries, allowing them to stay in the game longer.
© Copyright 2025